High-Frequency Repetitive Transcranial Magnetic Stimulation Assists In Smoking Cessation
1 other identifier
interventional
50
1 country
1
Brief Summary
Cigarette smoking is a major public health problem causing significant morbidity and mortality. Yet, smoking cessation therapies are often ineffective at helping smokers break their addiction. The mesolimbic dopaminergic reward system plays a crucial role in mediating the reinforcing effects of nicotine. Recently, acute high frequency repetitive transcranial magnetic stimulation (rTMS) of frontal brain regions has been shown to efficiently modulate the mesolimbic dopamine systems in both animals and humans. For this reason, we investigated whether 10 high-frequency (10Hz) rTMS treatments over the left dorsolateral prefrontal cortex can help people to withdraw smoking in comparison to placebo rTMS. Smokers seeking to quit are recruited through newspaper advertisements. Participants were randomized to 10 days of either real or placebo high frequency rTMS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2005
CompletedFirst Submitted
Initial submission to the registry
January 30, 2006
CompletedFirst Posted
Study publicly available on registry
January 31, 2006
CompletedJune 30, 2011
June 1, 2011
January 30, 2006
June 29, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of cigarettes smoked
Study Arms (2)
Real high frequency rTMS
ACTIVE COMPARATORThe patients will undergo a series of treatments of high frequency rTMS
Sham high frequency rTMS
SHAM COMPARATORThe patients will receive a series of sham treatments.
Interventions
3\. rTMS subjects will receive 20 trains of rTMS at a rate of 10 Hz for 6 seconds (1200 pulses/session). Pulses will be administered over the left dorsolateral prefrontal cortex, defined as 5 cm anterior and in a parasagital plane to the point of maximum stimulation of the abductor pollicis muscle. Pulse intensity will be set at 100% motor threshold.
Sham stimulation will be given at the same location as the active, with special sham coil.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sheba Medical Center
Ramat Gan, 52621, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Revital A Amiaz, MD
Sheba Medical Center
- STUDY DIRECTOR
Abraham Zangen, Phd
Weizmann Institute of Science
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
January 30, 2006
First Posted
January 31, 2006
Study Start
July 1, 2005
Last Updated
June 30, 2011
Record last verified: 2011-06